RESUMEN
Lifestyle habits can have a profound impact on atherosclerotic cardiovascular disease (ASCVD) risk. The National Lipid Association previously published recommendations for lifestyle therapies to manage dyslipidemia. This Clinical Perspective provides an update with a focus on nutrition interventions for the three most common dyslipidemias in adults: 1) low-density lipoprotein cholesterol (LDL-C) elevation; 2) triglyceride (TG) elevation, including severe hypertriglyceridemia with chylomicronemia; and 3) combined dyslipidemia, with elevations in both LDL-C and TG levels. Lowering LDL-C and non-high-density lipoprotein cholesterol are the primary objectives for reducing ASCVD risk. With severe TG elevation (≥500 mg/dL), the primary objective is to prevent pancreatitis and ASCVD risk reduction is secondary. Nutrition interventions that lower LDL-C levels include reducing cholesterol-raising fatty acids and dietary cholesterol, as well as increasing intakes of unsaturated fatty acids, plant proteins, viscous fibers, and reducing adiposity for patients with overweight or obesity. Selected dietary supplements may be employed as dietary adjuncts. Nutrition interventions for all patients with elevated TG levels include restricting intakes of alcohol, added sugars, and refined starches. Additional lifestyle factors that reduce TG levels are participating in daily physical activity and reducing adiposity in patients with overweight or obesity. For patients with severe hypertriglyceridemia, an individualized approach is essential. Nutrition interventions for addressing concurrent elevations in LDL-C and TG include a combination of the strategies described for lowering LDL-C and TG. A multidisciplinary approach is recommended to facilitate success in making and sustaining dietary changes and the assistance of a registered dietitian nutritionist is highly recommended.
Asunto(s)
Aterosclerosis , Dislipidemias , Hiperlipidemias , Hipertrigliceridemia , Humanos , Adulto , LDL-Colesterol , Sobrepeso , Colesterol , Dislipidemias/tratamiento farmacológico , Triglicéridos , Aterosclerosis/tratamiento farmacológico , ObesidadRESUMEN
A diet high in saturated fatty acids (SFA) is a suspected contributor to atherosclerotic cardiovascular disease (ASCVD) risk, in large part because of an effect to raise the low-density lipoprotein cholesterol (LDL-C) concentration. Most dietary guidance from health authorities advocates limiting intake of SFA, particularly for people with clinical ASCVD, dyslipidemia, or diabetes mellitus. However, recent reviews have highlighted controversies regarding SFA intake and cardiovascular health. This brief editorial commentary includes a discussion of the evidence regarding SFA intake and cardiovascular health, outlines gaps in the available evidence, and proposes tentative conclusions based on what is known today about SFA consumption and ASCVD risk. Results from observational studies demonstrate that dietary patterns with lower average intakes of SFA are associated with favorable cardiovascular outcomes. Additionally, although the number of randomized controlled trials testing the effects of reducing SFA intake on ASCVD outcomes is limited, the available evidence supports the view that replacing SFA with unsaturated fatty acids, particularly polyunsaturated fatty acids, may reduce ASCVD risk. Beyond raising LDL-C and atherogenic lipoprotein particle concentrations, higher intakes of SFA may influence pathways affecting inflammation, cardiac rhythm, hemostasis, apolipoprotein CIII production, and high-density lipoprotein function. However, the impacts of these effects on ASCVD risk remain uncertain. In the authors' view, the totality of the evidence supports the current recommendation to limit SFA intake to <10% of total daily energy for the general healthy population and further (e.g., to 5-6% of total daily energy) for patients with hypercholesterolemia.
Asunto(s)
Aterosclerosis/diagnóstico , Enfermedades Cardiovasculares/diagnóstico , Sistema Cardiovascular/metabolismo , Ácidos Grasos/administración & dosificación , Apolipoproteínas B/metabolismo , Aterosclerosis/etiología , Biomarcadores/metabolismo , Enfermedades Cardiovasculares/etiología , Sistema Cardiovascular/efectos de los fármacos , LDL-Colesterol/metabolismo , Grasas de la Dieta/administración & dosificación , Grasas de la Dieta/efectos adversos , Ácidos Grasos/efectos adversos , Humanos , Lipoproteínas HDL/metabolismo , Factores de RiesgoRESUMEN
This study examined the use of herbal, botanical, and nonherbal dietary supplements (referred to as nonvitamin, nonmineral [NVNM] supplements) among rural older adults residing in southeast and south central Idaho, and explored perceptions of the safety and efficacy of these supplements. Data were collected from a convenience sample of 365 rural older adults participating in a congregate meals program at a local senior center using a written questionnaire developed for the study. Of the 365 study participants, 39.5% reported using NVNM supplements in the past 12 months. The majority of the participants felt that the NVNM supplements they used were effective, and few reported adverse effects. The majority of the participants felt that NVNM supplements were safe; however, safety concerns were expressed specifically in terms of concurrent use with prescription medication.